TODESCHINI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.722
EU - Europa 872
AS - Asia 454
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 3.055
Nazione #
US - Stati Uniti d'America 1.711
PL - Polonia 348
CN - Cina 208
UA - Ucraina 145
IT - Italia 106
DE - Germania 102
SG - Singapore 99
HK - Hong Kong 73
FI - Finlandia 62
IE - Irlanda 28
GB - Regno Unito 27
TR - Turchia 27
RU - Federazione Russa 25
VN - Vietnam 16
CA - Canada 9
SE - Svezia 8
FR - Francia 7
IN - India 6
BE - Belgio 5
ID - Indonesia 5
KR - Corea 4
TW - Taiwan 4
KG - Kirghizistan 3
BR - Brasile 2
CZ - Repubblica Ceca 2
EU - Europa 2
IQ - Iraq 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MX - Messico 2
NL - Olanda 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
MU - Mauritius 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 3.055
Città #
Warsaw 348
Fairfield 248
Woodbridge 178
Ashburn 127
Houston 120
Seattle 117
Jacksonville 102
Ann Arbor 99
Chandler 94
Cambridge 87
Wilmington 86
Singapore 84
New York 64
Dearborn 59
Hong Kong 56
Princeton 48
Helsinki 43
Nanjing 31
Brescia 30
Dublin 28
Istanbul 26
Beijing 24
Shanghai 23
Jinan 18
Dong Ket 16
Los Angeles 15
Moscow 14
Central 13
Hangzhou 11
Shenyang 11
Hebei 10
Jiaxing 10
Kunming 10
Milan 10
Des Moines 9
Toronto 9
London 8
San Diego 8
Changsha 7
Lanzhou 7
Nanchang 7
Monmouth Junction 6
Tianjin 6
Brussels 5
Leawood 5
Ningbo 5
Cazzago San Martino 4
Falkenstein 4
Hefei 4
Jakarta 4
Nardò 4
Rome 4
Arezzo 3
Bishkek 3
Espoo 3
Kilburn 3
Munich 3
North 3
Norwalk 3
Taoyuan District 3
Baghdad 2
Baton Rouge 2
Boardman 2
Cheongju-si 2
Colombo 2
Guangzhou 2
Haikou 2
Luxembourg 2
Mexico City 2
Pavia 2
Phoenix 2
Romola 2
San Bruno 2
San Francisco 2
San Mateo 2
South San Francisco 2
Verona 2
Wuhan 2
Zhengzhou 2
Almaty 1
Almere Stad 1
Amman 1
Ardabil 1
Auburn Hills 1
Borgo San Giacomo 1
Boston 1
Brno 1
Buccinasco 1
Campinas 1
Chengdu 1
Chicago 1
Chongqing 1
Gunzenhausen 1
Göttingen 1
Islington 1
Kocaeli 1
Lancaster 1
Lincoln 1
Medford 1
Melbourne 1
Totale 2.449
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 290
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 261
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 228
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 153
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 143
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 141
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 132
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 131
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 129
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 125
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 122
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 117
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 112
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin. 111
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 111
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 106
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 100
EXPRESSION PATTERN AND MOLECULAR FUNCTION OF TRASCRIPTION FACTOR FOXM1 (FORKHEAD BOX PROTEIN M1) IN EPITHELIAL OVARIAN CANCER CLINICAL SPECIMENS AND CELL LINES 88
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 79
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 78
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 66
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 63
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 59
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 58
Integrated mutational landscape analysis of uterine leiomyosarcomas 37
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 31
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 29
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 23
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 8
Totale 3.131
Categoria #
all - tutte 14.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020467 0 0 0 0 0 109 89 81 62 71 19 36
2020/2021498 12 52 8 60 15 46 35 57 46 89 48 30
2021/2022274 38 53 2 4 1 13 21 12 10 44 27 49
2022/2023292 48 15 13 13 25 53 5 31 53 2 17 17
2023/2024386 21 12 42 23 20 96 20 26 64 22 9 31
2024/2025212 6 12 6 83 37 68 0 0 0 0 0 0
Totale 3.131